Journal profile · Medicine-Hematology
Journal of the National Cancer Center
ISSN 2667-0054 · Elsevier · Netherlands
Journal of the National Cancer Center: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 25.2 (journal website); fully open access; APC about USD 2,700; median 160 days to acceptance (89 articles, last 24 months); 68 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of the National Cancer Center is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, Cancer Immunotherapy and Biomarkers and Diverse Scientific and Economic Studies, together about 21.7% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of the National Cancer Center (JNCC) is a peer-reviewed and fully open-access journal that publishes high-quality articles in all areas of cancer research. Launched in March 2021, the journal aims to promote studies that answer fundamental questions of cancer biology and epidemiology, and facilitate state-of-the-art approaches for cancer prevention, detection, diagnosis, and treatment. As a prominent platform to communicate advances in cancer research and cancer-related health policies, the journal presents original research articles, news stories, systematic and focused reviews, commentaries, brief communications, correspondences, and editorials.JNCC adopts an efficient process of rigorous yet rapid review of submitted manuscripts so that timely findings of significant scientific impact can be published with minimal delay. JNCC particularly encourages submission of randomized controlled clinical trials, for which expedited review process will be provided. The journal now publishes on a bimonthly basis.JNCC is supervised by the National Health Commission of China and is sponsored by the National Cancer Center (NCC). NCC is the national authority for cancer prevention and control in China.The main responsibilities of NCC include: Assist the National Health Commission in developing national cancer prevention and control strategies;Organize and oversee the national cancer registration network, release the annual report of the national cancer registry;Establish clinical guidelines for cancer diagnosis and treatment;Promote and facilitate clinical trials for new drugs and devices for cancer treatment;Build programs for cancer screening and early detection;Develop and implement effective cancer primary preventive strategies;Conduct scientific research on cancer prevention and control;Carry out relevant trainings, academic exchanges, and international cooperation with International Agency for Research on Cancer (IARC), U.S. National Cancer Institute (NCI), Asian National Cancer Center Alliance (ANCCA), Cancer Research UK (CRUK), and prestigious universities, etc.;Undertake other tasks assigned by the National Health Commission.The editorial office of JNCC is in Beijing, China.P-ISSN 2096-8663
From the journal's Aims & Scope
Research area (LetPub): Medicine-Hematology
Editor-in-chief Jie HePublisher website
Editorial board by country: 26 in mainland China (about 47%); most named Mainland China 26, United States 14, United Kingdom 3, Hong Kong, China 2, Germany 2 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine9%
- Cancer Immunotherapy and BiomarkersMedicine7%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.7%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.3%
- Human auditory perception and evaluationEngineering5.3%
- Educational Robotics and EngineeringComputer Science5.3%
- Lung Cancer Treatments and MutationsMedicine4.8%
- Lung Cancer Diagnosis and TreatmentMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 25.2Publisher website ·
- CiteScore 2026-06
- 31.2LetPub ·
- CiteScore (publisher)
- 31.2Publisher website ·
- SJR 2026-06
- 5.05LetPub ·
- SNIP 2026-06
- 7.29LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 81OpenAlex ·
- 2-year mean citedness
- 18.59OpenAlex ·
- Self-citation rate
- 1.2%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 52LetPub ·
Articles by year OpenAlex count · 311 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 67 | 67 | 22 |
| 2025 | 68 | 68 | 560 |
| 2024 | 57 | 57 | 2,987 |
| 2023 | 43 | 43 | 443 |
| 2022 | 44 | 44 | 2,409 |
| 2021 | 31 | 31 | 363 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
160 daysMedian, submission to acceptance · P25–P75 100 days – 214 days
- Acceptance to online
- median 28 days (89 articles)
- Submission to online
- median 201 days
- Sample
- 89 articles with submission and acceptance dates (119 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- First decision after review
- 56 daysPublisher website ·
- Submission to acceptance
- 141 daysPublisher website ·
- Acceptance to publication
- 39 daysPublisher website ·
- Submission to publication (journal-reported)
- about 49 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,700 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,160 / EUR 1,970 / GBP 1,730 / JPY 254,840 | — | — | |
| LetPub | USD 1,800 | Yes | — | |
| Publisher website | USD 2,700 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 6,000 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted10, with length limits
- commentaryArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …main text ≤ 1,000 words
- correspondenceArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …Length not stated
- editorialArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …main text ≤ 1,000 words
- meta-analysisArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …Length not stated
- perspectiveArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …Length not stated
- practice guideline and consensusA Practice Guideline refers to a public statement from an organization or representative group of experts that includes evidence-based recommendations to inform…Length not stated
- research articleArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …Length not stated
- reviewArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …Length not stated
- short communicationArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …Length not stated
- systematic reviewArticle types include but are not limited to research articles, reviews, perspectives, short communications, correspondence, practice guidelines, commentaries, …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2667-0054
- Print ISSN
- 2096-8663
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of the National Cancer Center
What CAS zone is Journal of the National Cancer Center in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of the National Cancer Center is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of the National Cancer Center?
The journal's website gives an impact factor of 25.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 31.2, h-index 26.
How long does peer review take at Journal of the National Cancer Center?
Based on the dates recorded on 89 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 160 days (interquartile range 100–214 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of the National Cancer Center?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Manuscript length: ≤ 6,000 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of the National Cancer Center based?
Of the 55 board members whose country the journal's board page names, 26 (about 47%) are in mainland China; the countries named most often are Mainland China (26), United States (14) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of the National Cancer Center?
According to LetPub and DOAJ records, Journal of the National Cancer Center is indexed in ESCI, Scopus and DOAJ.
Is Journal of the National Cancer Center open access, and what is the APC?
Journal of the National Cancer Center is a fully open-access journal. APC about USD 2,700.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .